by The cell surface markers detection market has emerged as a key diagnostic segment to detect rare and circulating tumor cells. Cell surface markers play an important role in immune profiling and identification of different cell types. Advances in immunoassay techniques such as enzyme-linked immunosorbent assay (ELISA), flow cytometry, Western blot, and other immunoblotting methods have enabled early detection of abnormal cells.
The global cell surface markers detection market is estimated to be valued at US$ 6506.69 Mn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F.
Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD),
Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others. The rising prevalence of cancer globally has increased the demand for early detection and treatment of the disease. Growing adoption of cell surface markers detection techniques in clinical research, companion diagnostics, and drug discovery is expected to drive market growth. Key players are expanding their geographic presence into emerging markets of Asia Pacific and Latin America to gain higher shares.
Market key trends
Cell Surface Markers Detection Market growth is being driven by the emergence of immunotherapy approaches for treating cancer, which has boosted research activities around developing antibody-based therapeutics targeting specific cell surface markers. Monoclonal antibodies that bind to tumor-associated antigens are being evaluated to enhance the immune response against cancer cells.Moreover, cell surface protein biomarkers help identify patients eligible for immunotherapies. This rising focus on precision medicine through biomarkers is expected to steer the cell surface markers detection market over the forecast period.
Porter’s Analysis
Threat of new entrants: Low capital requirements due to availability of low-cost reagents and instruments for cell surface markers detection.
Bargaining power of buyers: Buyers have high bargaining power due to presence of substitute detection methods.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated reagents and instruments used for detection of cell surface markers. Threat of new substitutes: Substitute detection methods like flow cytometry pose threat to cell surface markers detection market.
Competitive rivalry: Cell Surface Markers Detection Market Challenges and Opportunities are influenced by the high degree of competition due to the presence of international players offering a diverse portfolio of reagents and instruments.
Geographical regions where the market is concentrated in terms of value:
North America holds the largest share of cell surface markers detection market owing to increasing R&D expenditure and advanced healthcare infrastructure in the US and Canada. Asia Pacific is the fastest growing regional market due to improving healthcare facilities, rising healthcare expenditure, and increasing incidence of chronic and infectious diseases in major Asian countries like China and India.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. LinkedIn
